Effects of Crataegus azarolus Extracts on Proliferation, Migration, and Apoptosis in AGS Gastric Cancer Cell Line
DOI:
https://doi.org/10.14500/aro.12397Keywords:
Anti-proliferative, Apoptosis, Crataegus extracts, Gastric cancer, Human adenocarcinoma gastricAbstract
Gastric cancer remains one of the leading causes of cancer morbidity and death worldwide. Despite advances, current treatments remain costly, have low success rates, and cause adverse effects, prompting research into plant-based alternatives as a potential solution. Crataegus azarolus contains compounds with health potential and minimal side effects. This study investigates the potential antiproliferative, migratory, and apoptotic effects of C. azarolus methanol and acetone extracts of fruits and leaves on human gastric adenocarcinoma cell lines (AGS) and human fibroblast cell lines. AGS cells were treated with different concentrations of methanol and acetone fruits (MF and AF) extracts (10, 50, 100, 250, and 500 μg/mL). The results demonstrates that MF extract showes significantly higher anti-proliferative activity at 500μg/mL concentrations, when estimated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay (p < 0.001). The calculated half-maximal inhibitory concentration value is 300μg/mL. Furthermore, MF extract showes a significant (p ˂ 0.01) cellular migration inhibitory effect. The clonogenicity of AGS is considerably inhibited (p < 0.001), resulting in a decrease in holoclone production in AF and acetone leave (AL) extracts. Flow cytometry reveales induction of apoptosis, with highest 31.4% MF. Early growth response-1 expression increases dramatically (p < 0.001) in AF extract, while enhancer of zeste homolog-2 expression increases significantly (p< 0.001) when treated with MF and AL. Phosphatase and tensin homolog and N-myc downstream regulated gene-1 are both highly upregulated in MF and AF extracts, respectively. In conclusion, C. azarolus demonstrates anti-cancer effects on AGS cell line and may have potential as a source of anticancer compounds.
Downloads
References
Barrandon, Y., and Green, H., 1987. Three clonal types of keratinocyte with different capacities for multiplication. Proceedings of the National Academy of Sciences U S A, 84, pp.2302-2306.
Barzani, H.A.H., Ali, H.S., Anwar Omer, R., Sulaiman, S.H., Salih, M.I., and Qader, A.F., 2025. Quantifying nitrosoureas: Comprehensive insights into analytical techniques transforming cancer research. Critical Reviews in Analytical Chemistry, 55, pp.1-22.
Castellón, E.A., Valenzuela, R., Lillo, J., Castillo, V., Contreras, H.R., Gallegos, I., Mercado, A., and Huidobro, C., 2012. Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis. Biological Research, 45, 297-305.
Chen, D.L., Zhang, D.S., Lu, Y.X., Chen, L.Z., Zeng, Z.L., He, M.M., Wang, F.H., Li, Y.H., Zhang, H.Z., Pelicano, H., Zhang, W., and Xu, R.H., 2015. microrna-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Oncotarget, 6, pp.10868-10879.
Deveci, E., Cayan, G.T., Karakurt, S., and Duru, M.E., 2020. Antioxidant, cytotoxic, and enzyme inhibitory activities of agropyron repens and Crataegus monogyna species. European Journal of Biology, 79, pp.98-105.
Franken, N.A., Rodermond, H.M., Stap, J., Haveman, J., and Van Bree, C., 2006. Clonogenic assay of cells in vitro. Nature Protocols, 1, pp.2315-2319.
Guan, W.L., He, Y., and Xu, R.H., 2023. Gastric cancer treatment: Recent progress and future perspectives. Journal Hematology Oncology, 16, p.57.
Habli, Z., Toumieh, G., Fatfat, M., Rahal, O.N., and Gali-Muhtasib, H., 2017. Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms. Molecules, 22, p.250.
Harborne, J., 1984. Phytochemical Methods. 2nd ed. Chapman and Hall, London, New York.
Huang, H., Fang, J., Fan, X., Miyata, T., Hu, X., Zhang, L., Zhang, L., Cui, Y., Liu, Z., and Wu, X., 2020. Advances in molecular mechanisms for traditional Chinese medicine actions in regulating tumor immune responses. Frontiers in Pharmacology, 11, p.1009.
Hussain, A.M., and Lafta, R.K., 2021. Cancer trends in Iraq 2000-2016. Oman Medical Journal, 36, p.e219.
Indran, I.R., Tufo, G., Pervaiz, S., and Brenner, C., 2011. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochimica Biophysica Acta - Bioenergetics, 1807, pp.735-45.
Lakache, Z., Tigrine-Kordjani, N., Tigrine, C., Aliboudhar, H., and Kameli, A., 2016. Phytochemical screening and antioxidant properties of methanolic extract and different fractions of Crataegus azarolus leaves and flowers from Algeria. International Food Research Journal, 23, pp.1576-1583.
Liu, H.T., Liu, S., Liu, L., Ma, R.R., and Gao, P., 2018. EGR1-mediated transcription of lncRNA-HNF1A-AS1 promotes cell-cycle progression in gastric cancer. Cancer Research, 78, pp.5877-5890.
Ma, L., Xu, G.B., Tang, X., Zhang, C., Zhao, W., Wang, J., and Chen, H., 2020. Anti-cancer potential of polysaccharide extracted from hawthorn (Crataegus.) On human colon cancer cell line HCT116 via cell cycle arrest and apoptosis. Journal of Functional Foods, 64, p.103677.
Ma, Z., Gao, X., Shuai, Y., Wu, X., Yan, Y., Xing, X., and Ji, J., 2021. EGR1 mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer. Cell Proliferation, 54, p.e12922.
Majrashi, T.A., Alshehri, S.A., Alsayari, A., Muhsinah, A.B., Alrouji, M., Alshahrani, A.M., Shamsi, A., and Atiya, A., 2023. Insight into the biological roles and mechanisms of phytochemicals in different types of cancer: Targeting cancer therapeutics. Nutrients, 15, p.1704.
Mohamad, T., Kazim, N., Adhikari, A., and Davie, J.K., 2018. EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma. Oncotarget, 9, pp.18084-18098.
Mohamad, T.S., 2017. Early Growth Response 1 (EGR1) as a Tumor Suppressor and Apoptosis Inducer in Rhabdomyosarcoma. Southern Illinois University, Carbondale.
M-Amen, K., Abdullah, O.S., Amin, A.M.S., Mohamed, Z.A., Hasan, B., Shekha, M., Najmuldeen, H.H., Rahman, F.M., Housein, Z., Salih, A.M., Mohammed, A.S., Sulaiman, L.R., Barzingi, B.T., Mahmood, D., Othman, H.E., Mohammad, D.K., Salih, F.M., Ali, S.A.K., Mohamad, T.S.,… & Salihi A., 2022. Cancer Incidence in the Kurdistan Region of Iraq: Results of a seven-year cancer registration in Erbil and Duhok Governorates. Asian Pacific Journal of Cancer Prevention, 23, pp.601-615.
Mohammedsaeed, A.A., and Mohamad, T.S., 2023. Inhibitory and anti-cancer effects of Crataegus azarolus extracts on gastric cancer cell line (AGS). Zanco Journal of Pure and Applied Sciences, 35, pp.211-220.
Mustapha, N., Bzéouich, I.M., Ghedira, K., Hennebelle, T., and Chekir-Ghedira, L., 2015. Compounds isolated from the aerial part of Crataegus azarolus inhibit growth of B16F10 melanoma cells and exert a potent inhibition of the melanin synthesis. Biomedicine and Pharmacotherapy, 69, pp.139-144.
Niu, Z., Yan, M., Zhao, X., Jin, H., and Gong, Y., 2020. Effect of hawthorn seed extract on the gastrointestinal function of rats with diabetic gastroparesis. South African Journal of Botany, 130, pp.448-455.
Omairi, I., Kobeissy, F., and Nasreddine, S., 2020. Anti-oxidant, anti-hemolytic effects of Crataegus aronia leaves and its anti- proliferative effect enhance Cisplatin cytotoxicity in A549 human lung cancer cell line. Asian Pacific Journal Cancer Prevention, 21, pp.2993-3003.
Rastogi, S., Pandey, M.M., and Rawat, A.K., 2016. Traditional herbs: A remedy for cardiovascular disorders. Phytomedicine, 23, pp.1082-1089. Shimizu, S., Yoshida, T., Tsujioka, M., and Arakawa, S., 2014. Autophagic cell death and cancer. International Journal Molecular Science, 15, pp.3145-3153.
Sulaiman, S.H., and Demir, H., 2023. Exploring the impact of trace elements and heavy metals on colon cancer. Medical Science and Discovery, 10, pp.736-743.
Sun, B., Wang, G., Liu, H., Liu, P., Twal, W.O., Cheung, H., Carroll, S.L., Ethier, S.P., Mevers, E.E., Clardy, J., Roberts, T., Chen, C., Li, Q., Wang, L., Yang, M., Zhao, J.J., and Wang, Q., 2018. Oridonin inhibits aberrant AKT activation in breast cancer. Oncotarget, 9, pp.23878-23889.
Wang, X., Zhang, N., Huo, Q., Sun, M., Dong, L., Zhang, Y., Xu, G., and Yang, Q., 2014. Huaier aqueous extract inhibits stem-like characteristics of MCF7 breast cancer cells via inactivation of hedgehog pathway. Tumor Biology, 35, pp.10805-10813.
Wong, M.C.S., Huang, J., Chan, P.S.F., Choi, P., Lao, X.Q., Chan, S.M., Teoh, A., and Liang, P., 2021. Global incidence and mortality of gastric cancer, 1980-2018. JAMA Netw Open, 4, p.e2118457.
Xiao, X.J., and Zheng, H.C., 2020. NDRG1 was downregulated and worked as favorable biomarker in the development of gastric cancer. Translational Cancer Research, 9, pp.210-221.
Xu, J., Wang, Z., Lu, W., Jiang, H., Lu, J., Qiu, J., and Ye, G., 2019a. EZH2 promotes gastric cancer cells proliferation by repressing p21 expression. Pathology Research and Practice, 215, p.152374.
Xu, W.T., Yang, Z., and Lu, N.H., 2014. Roles of PTEN (Phosphatase and Tensin Homolog) in gastric cancer development and progression. Asian Pacific Journal Cancer Prevention, 15, pp.17-24.
Xu, X., Lai, Y., and Hua, Z.C., 2019b. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Bioscience Reports, 39, pp 1-17.
Yang, Y., Wu, F., Zhang, J., Sun, R., Li, F., Li, Y., Chang, S.E., Wang, L., Wang, X., Liu, L., and Huang, C., 2019. EGR1 interacts with DNMT3L to inhibit the transcription of miR‐195 and plays an anti‐apoptotic role in the development of gastric cancer. Journal of Cellular and Molecular Medicine, 23, pp.7372-7381.
Zheng, G., Ma, Y., Zou, Y., Yin, A., Li, W., and Dong, D., 2018a. HCMDB: The human cancer metastasis database. Nucleic Acids Research, 46, pp.D950-D955.
Zheng, H.C., Qiu, Y.H., Qiu, Y.H., and Zhao, S., 2018b. The roles of PTEN expression in gastric cancer: A bibliometric meta and bioinformatics analysis. Oncotarget, 9, pp.s1074-s1089.
Zurek, N., Karatsai, O., Redowicz, M.J., and Kapusta, I.T., 2021. Polyphenolic compounds of Crataegus berry, leaf, and flower extracts affect viability and invasive potential of human glioblastoma cells. Molecules, 26, p.2656.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ali A. Mohammedsaeed, Trefa S. Mohamad
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who choose to publish their work with Aro agree to the following terms:
-
Authors retain the copyright to their work and grant the journal the right of first publication. The work is simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0]. This license allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
-
Authors have the freedom to enter into separate agreements for the non-exclusive distribution of the journal's published version of the work. This includes options such as posting it to an institutional repository or publishing it in a book, as long as proper acknowledgement is given to its initial publication in this journal.
-
Authors are encouraged to share and post their work online, including in institutional repositories or on their personal websites, both prior to and during the submission process. This practice can lead to productive exchanges and increase the visibility and citation of the published work.
By agreeing to these terms, authors acknowledge the importance of open access and the benefits it brings to the scholarly community.
Accepted 2026-05-14
Published 2026-07-24
ARO Journal is a scientific, peer-reviewed, periodical, and diamond OAJ that has no APC or ASC.